机器学习预测代谢功能障碍相关脂肪性肝病患者的肝纤维化
本研究基于超过3600例经活检确诊的代谢功能障碍相关脂肪性肝病患者,利用22项临床特征、肝脏硬度测量和受控衰减参数开发并验证了多种机器学习模型以区分肝纤维化分期。特征分词器Transformer和TabNet在二分类任务中表现最佳,曲线下面积分别达0.860和0.855(F≥3 vs 0-F2),显著优于FIB-4指数。结论认为,具备序数感知架构的深度学习模型可准确预测肝纤维化分期,为活检提供可扩展的替代方案。
要点
- 特征分词器Transformer和TabNet在F≥3 vs 0-F2任务中AUC分别为0.860和0.855。
- 多分类分期中,序数多层感知机(CORAL框架)的二次加权kappa为0.616。
核心结论
- 具备序数感知架构的深度学习模型能利用常规临床数据准确预测肝纤维化分期,无需特殊生物标志物。
研究设计与样本
- 在超过3600例经活检确诊的代谢功能障碍相关脂肪性肝病患者中开发并验证机器学习模型,使用22项临床特征、肝脏硬度测量和受控衰减参数;三个中心预设为地理外部验证,其余中心按75/25分层拆分训练池与内部随机测试集,训练池采用分层10折交叉验证调参,对5个插补数据集各训练1个模型(内部80/20拆分用于早停和操作点选择),性能按Rubin规则合并。
主要发现
- 特征分词器Transformer和TabNet在二分类任务中性能最高:F≥3 vs 0-F2的AUC分别为0.860和0.855,F≥2 vs 0-F1的AUC分别为0.800和0.788,均显著优于FIB-4指数。
- 多分类分期中序数模型表现最佳,多层感知机结合一致秩逻辑框架的二次加权kappa为0.616。
临床怎么用
- 可利用常规临床特征、肝脏硬度测量和受控衰减参数构建的深度学习模型辅助肝纤维化分期,减少对活检的依赖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Accurate staging of liver fibrosis is crucial for risk stratification in patients with metabolic dysfunction-associated steatotic liver disease. We aimed to develop and validate artificial intelligence-based models capable of distinguishing fibrosis stages. METHODS: We developed and validated machine learning models to predict fibrosis stages in more than 3600 biopsy-confirmed patients with metabolic dysfunction-associated steatotic liver disease using 22 clinical features, liver stiffness measurement, and controlled attenuation parameter. Models included Feature Tokenizer Transformer, TabNet variants with distance-aware losses, ordinal Multilayer Perceptron with the COnditional RAnk Logits framework. Three centers were prespecified for geographic external validation. In the remaining centers, we used a stratified 75/25 split into a training pool and an internal random test set, tuned hyperparameters by stratified 10-fold cross-validation on the training pool, and trained 1 model per imputed dataset (M = 5) with an internal 80/20 train-validation split for early stopping and operating-point selection. Performance was pooled across imputations using Rubin's rules and reported for the internal random test set and the held-out centers. RESULTS: Feature Tokenizer Transformer and TabNet achieved the highest performance in binary tasks: area under the receiver operating characteristic curve = 0.860 and 0.855 (F ≥3 vs 0-F2) and area under the receiver operating characteristic curve = 0.800 and 0.788 (F ≥2 vs 0-F1), significantly outperforming the Fibrosis-4 index. For F ≥3, Feature Tokenizer Transformer had significantly higher area under the receiver operating characteristic curve than liver stiffness measurement (P = .014) but only marginally higher than AGILE3+, and, together with TabNet, the highest accuracy and the lowest gray zone (8.2% and 8.4%, respectively). For multiclass staging, ordinal models performed best with Multilayer Perceptron with the Consistent Rank Logits achieving quadratic weighted kappa = 0.616. CONCLUSIONS: Deep learning models with ordinal-aware architectures can accurately predict liver fibrosis stages using routinely available clinical data, offering a scalable alternative to biopsy without requiring specialized biomarkers.
引用
- Petta S, Pennisi G, Celsa C, et al. Machine Learning Prediction of Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Clin Gastroenterol Hepatol. 2026. PMID: 42476208. doi:10.1016/j.cgh.2026.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。